ENDRA Life Sciences Inc (NDRA) Stock Analysis
Verdict: AVOID
Zero revenue and a 2-month cash runway make ENDRA a binary bankruptcy risk, with survival entirely dependent on the NOBA merger outcome.
Investment score: 22/100
Analysis as of
Is ENDRA Life Sciences Inc stock worth reviewing? AI model thesis
The model identifies ENDRA as a 'zombie' company—effectively a shell for its ultrasound IP with no commercial traction and failing liquidity. The proposed merger with Noble Africa is the only path to survival, but the current valuation is disconnected from its $0.00 revenue reality.
7-factor investment score
- Valuation: 15/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
ENDRA Life Sciences Inc opportunities and risks
What speaks for NDRA
- Completion of NOBA Merger
What speaks against NDRA
- Immediate Liquidity Exhaustion
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| NDRA | n/a | 0.0x | n/a | 0.0% | 0.0% | -213.3% |
| HSCS | n/a | 735.0x | 442.7x | -1060.2% | -97881.0% | -53523.5% |
| NXL | n/a | 26.5x | n/a | -102.9% | -3022.9% | -72.5% |
| NVNO | n/a | 0.0x | 0.1x | 0.0% | 0.0% | -8269.2% |
| SCND | n/a | 1.1x | n/a | 31.4% | -15.7% | -103.1% |
| TNON | n/a | 0.8x | n/a | 64.2% | -268.3% | -305.5% |
| Peer median | n/a | 1.1x | n/a | 0.0% | -268.3% | -305.5% |
Frequently asked questions about ENDRA Life Sciences Inc (NDRA)
Is NDRA stock a good investment?
The cached TradeMates AI model rates ENDRA Life Sciences Inc as AVOID with an investment score of 22/100. The model identifies ENDRA as a 'zombie' company—effectively a shell for its ultrasound IP with no commercial traction and failing liquidity. The proposed merger with Noble Africa is the only path to survival, but the current valuation is disconnected from its $0.00 revenue reality. This is algorithmic model output, not personal investment advice.
Is NDRA stock a buy?
The TradeMates model verdict for NDRA is AVOID with an investment score of 22/100. Treat this as a model signal to review, not a personal buy recommendation.